• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
?

FDA Workshop on Drug Development for Chronic Fatigue Syndrome (CFS) and Myalgic Encephalomyelitis (ME)

The public workshop was held on April 25-26, 2013 at the Bethesda Marriott (5151 Pooks Hill Road, Bethesda, MD 20814). On April 25th, FDA gathered patients’ perspectives on CFS and ME through a facilitated group discussion focusing on two main topics:  (1) disease symptoms and daily impacts that matter most to patients; and (2) patients’ perspectives on current approaches to treating CFS and ME. The second day included a scientific discussion with patients, clinicians, researchers and government experts focusing on how to identify quantitative outcome measures to determine if disease symptoms improve with specific drug interventions.